Top

Reactions Weekly

Published in:

01-06-2023 | Neuroblastoma | Case report

Antineoplastic drugs

Neutropenia and no response: 15 case reports

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Mastrangelo S, et al. Induction Regimen in High-Risk Neuroblastoma: A Pilot Study of Highly Effective Continuous Exposure of Tumor Cells to Radio-Chemotherapy Sequence for 1 Month. The Critical Role of Iodine-131-Metaiodobenzylguanidine. Cancers 14: No. 20, 21 Oct 2022. Available from: URL: http://doi.org/10.3390/cancers14205170

Title: Antineoplastic drugs
Neutropenia and no response: 15 case reports
Publication date: 01-06-2023
Publisher: Springer International Publishing
Keywords: Neuroblastoma
Neuroblastoma
Neutropenia
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-41712-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Antineoplastic drugs

Neutropenia and no response: 15 case reports

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Multiple drugs

Multiple drugs

Anakinra/hydroxychloroquine

Oxybutynin

Multiple drugs misuse

Amoxicillin/clarithromycin/esomeprazole